Background
Hepatitis delta virus (HDV) infection in people with hepatitis B virus (HBV) accelerates the progression of liver disease and is associated with a higher risk of cirrhosis and hepatocellular carcinoma. The DDR Spain initiative was designed to harmonize HDV diagnosis across the country through reflex anti-HDV and HDV-RNA testing, while providing a comprehensive description of individuals with HDV in Spain.
Methods
DDR Spain is a multicenter, nationwide, ambispective, observational study, including a retrospective evaluation of diagnostic practices in 2022–2023 and a prospective arm initiated in 2024. The prospective phase systematically collects clinical, demographic, and virological information from individuals who tested anti-HDV-positive enrolled in participating centers.
Results
Between 2022 and 2024, 65,763 HBsAg-positive individuals were included from 80 centers in 16 out of Spain’s 17 Autonomous Communities. Reflex anti-HDV implementation rose from 55.1% in 2022 to 85.8% in 2024 (p<0.05), while anti-HDV prevalence remained stable (5.6%, 4.9%, 5.3%). Regional heterogeneity persisted. HDV-RNA coverage increased from 72.6% in 2022 to 91% in 2024(p<0.05), and the proportion of active HDV infection declined from 40.3% to 31%. By September 2025, 370 individuals who tested anti-HDV-positive were prospectively recruited: median age was 55 years (IQR 42–61), 56% male, and 50% Spanish-born. Genotype 1 was predominant (87%). 16% were individuals with HIV and 20% with HCV. Indicators of advanced fibrosis were notable: 27% had FIB-4 >2.67 and among 153 individuals with transient elastography, mean liver stiffness was 7.8 kPa; 15% had METAVIR F3 and 29% F4. Previous hepatic decompensation was documented in 22.7% of evaluable cases.
Conclusions
DDR Spain represents the largest effort to implement standardized HDV diagnosis nationwide. The project demonstrates marked progress in reflex testing and HDV-RNA coverage but underscores persistent regional disparities. The prospective cohort provides a detailed view of current HDV epidemiology in Spain, reinforcing the urgent need for harmonized screening strategies, professional training, and increased awareness to optimize HDV detection and management.